{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:48:50Z","timestamp":1788518930828,"version":"build-2803163510"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Hereditary systemic autoinflammatory diseases (SAIDs) are rare, often severe conditions characterised by mutations in the key regulators of innate immune responses. Dramatic advances in the molecular genetics and next-generation sequencing in the past decade enabled identification of novel mutations that play a pivotal role in the mechanistic pathways of inflammation. Although genetic testing may not always provide straightforward guidance in diagnosis and clinical decision making, through translational research, it sheds light into molecular immunopathogenesis, particularly in IL-1 inflammasome and cytokine signalling pathways. These remarkable insights provided a better understanding of autoinflammatory conditions and their association with the innate and adaptive immune systems, as well as leading to development of cytokine-targetted biologic treatments. Use of targetted therapeutics not only helps control disease flares, reduce acute-phase responses and prevent devastating complications such as amyloidosis, but also improves health-related quality of lives and support patients to pursue almost a normal life. Herein, we discuss the commonest monogenic SAIDs, describe their immunopathology, and summarise the approaches in the management and targetted treatment of these conditions, including presentation of novel data based on a cohort of children with these rare diseases from a single quaternary referral centre in London.<\/jats:p>","DOI":"10.3389\/fped.2022.867679","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:14:43Z","timestamp":1651151683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification"],"prefix":"10.3389","volume":"10","author":[{"given":"Ovgu","family":"Kul Cinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Putland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective.","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.berh.2017.12.001","article-title":"Periodic fever syndromes.","volume":"31","author":"Lachmann","year":"2017","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0952-7915(00)00124-2","article-title":"TNFRSF1A mutations and autoinflammatory syndromes.","volume":"12","author":"Galon","year":"2000","journal-title":"Curr Opin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/bor.0000174210.78449.6b","article-title":"Familial autoinflammatory diseases: genetics, pathogenesis and treatment.","volume":"17","author":"Stojanov","year":"2005","journal-title":"Curr Opin Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/annrheumdis-2011-201271","article-title":"Guidelines for the genetic diagnosis of hereditary recurrent fevers.","volume":"71","author":"Shinar","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/cge.13223","article-title":"Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: a systematic review.","volume":"94","author":"Gangemi","year":"2018","journal-title":"Clin Genet."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00333","article-title":"Functions of NOD-like receptors in human diseases.","volume":"4","author":"Zhong","year":"2013","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.cdd.4402038","article-title":"Inflammatory caspases and inflammasomes: master switches of inflammation.","volume":"14","author":"Martinon","year":"2007","journal-title":"Cell Death Differ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body.","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2015.79","article-title":"From bench to bedside and back again: translational research in autoinflammation.","volume":"11","author":"Holzinger","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease.","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/aci.0000000000000396","article-title":"NLRC4 inflammasomopathies.","volume":"17","author":"Romberg","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1.","volume":"214","author":"Standing","year":"2017","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.","volume":"130","author":"de Jesus","year":"2020","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","article-title":"Familial Mediterranean fever.","volume":"351","author":"Ben-Chetrit","year":"1998","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00253","article-title":"Familial mediterranean fever: recent developments in pathogenesis and new recommendations for management.","volume":"8","author":"Ozen","year":"2017","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever.","volume":"17","year":"1997","journal-title":"Nat Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4049\/jimmunol.179.2.1274","article-title":"Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release.","volume":"179","author":"Seshadri","year":"2007","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/art.24569","article-title":"Familial Mediterranean fever with a single MEFV mutation: where is the second hit?.","volume":"60","author":"Booty","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/art.24570","article-title":"Clinical disease among patients heterozygous for familial Mediterranean fever.","volume":"60","author":"Marek-Yagel","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/clpt.2013.148","article-title":"Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.","volume":"95","author":"Grattagliano","year":"2014","journal-title":"Clin Pharmacol Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.","volume":"513","author":"Xu","year":"2014","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006035","article-title":"The Yersinia pestis effector YopM inhibits pyrin inflammasome activation.","volume":"12","author":"Ratner","year":"2016","journal-title":"PLoS Pathog."},{"key":"B29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41590-020-0705-6","article-title":"Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.","volume":"21","author":"Park","year":"2020","journal-title":"Nat Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis.","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med."},{"key":"B32","article-title":"Colchicine for familial Mediterranean fever.","volume":"287","author":"Goldfinger","year":"1972","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever.","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B34","first-page":"616","article-title":"Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever.","volume":"31","author":"Fradkin","year":"1995","journal-title":"Isr J Med Sci."},{"key":"B35","first-page":"2620","article-title":"Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine.","volume":"30","author":"Lidar","year":"2003","journal-title":"J Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/s0049-0172(03)00137-9","article-title":"Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization.","volume":"33","author":"Lidar","year":"2004","journal-title":"Semin Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","article-title":"Colchicine resistance and intolerance in familial mediterranean fever: definition, causes, and alternative treatments.","volume":"47","author":"Ozen","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes.","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra.","volume":"66","author":"Kuijk","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B41","first-page":"1708","article-title":"Protracted febrile myalgia in patients with familial Mediterranean fever.","volume":"21","author":"Langevitz","year":"1994","journal-title":"J Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20102049","article-title":"Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).","volume":"208","author":"Bulua","year":"2011","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.it.2011.08.005","article-title":"Interplay between redox status and inflammasome activation.","volume":"32","author":"Rubartelli","year":"2011","journal-title":"Trends Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review.","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases.","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4065\/72.9.806","article-title":"Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family.","volume":"72","author":"McDermott","year":"1997","journal-title":"Mayo Clin Proc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/rheumatology\/kem231","article-title":"Comment on: failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).","volume":"46","author":"Drewe","year":"2007","journal-title":"Rheumatology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","article-title":"Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.","volume":"76","author":"Gattorno","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome.","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/jimd.12412","article-title":"Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria.","volume":"44","author":"Brennenstuhl","year":"2021","journal-title":"J Inherit Metab Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the eurofever registry.","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724991","article-title":"Compromised protein prenylation as pathogenic mechanism in mevalonate kinase deficiency.","volume":"12","author":"Politiek","year":"2021","journal-title":"Front Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion.","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","article-title":"Open-label, phase II study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome.","volume":"69","author":"Arostegui","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2.","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the clinical phenotype of adenosine deaminase 2 deficiency.","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase Type 2: a description of phenotype and genotype in fifteen cases.","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2.","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0334-5","article-title":"Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).","volume":"17","author":"Clarke","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00109-016-1465-5","article-title":"Insights from mendelian interferonopathies: comparison of CANDLE, SAVI with AGS, monogenic lupus.","volume":"94","author":"Kim","year":"2016","journal-title":"J Mol Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1172\/jci81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production.","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest."},{"key":"B71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview.","volume":"31","author":"Eleftheriou","year":"2017","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT Signaling as a target for inflammatory and autoimmune diseases: current and future prospects.","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02160-9","article-title":"Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.","volume":"22","author":"Kim","year":"2020","journal-title":"Arthritis Res Ther."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.867679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:14:50Z","timestamp":1651151690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.867679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":73,"alternative-id":["10.3389\/fped.2022.867679"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.867679","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"867679"}}